Merrimack

📍 Cambridge, United States🗓 Founded 2000👥 59 employees💰 Last funded 2001
Biotechnology Research🌐 merrimack.com
Website LinkedIn
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2000
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Merrimack?
Merrimack has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Merrimack last raise funding?
The most recent investment in Merrimack recorded on gritt.io was in 2001.
When was Merrimack founded?
Merrimack was founded in 2000.
What industry is Merrimack in?
Merrimack operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Merrimack based?
Merrimack is headquartered in Cambridge, United States.